Since different BC subtypes are largely distinct disease entities with divergent underlying biological/molecular driving mechanisms, specific miRNAs likely have opposite effects in luminal-like and hormone receptor-negative or HER2-amplified subtypes. The gene discussed is ERBB2; the disease is breast cancer.